#Pharma #GLP1 #ObesityTreatment #DrugDevelopment #HealthcareInnovation #EliLilly #NovoNordisk #PharmaceuticalIndustry To view or add a comment, sign in NEW DRUG APPROVAL ALERT The FDA has approved Foundayo (orforglipron), a new once-daily oral GLP-1 for chronic weight management in adults with obesity, or adults with overweight plus at least one weight-related condition
Widdicombe, 1995)
269 In a randomized, controlled, crossover trial in 11 healthy people, taking a lemon balm extract providing 500 mg rosmarinic acid per day for seven days was found to be safe and tolerable
Untreated control group had an average weight loss of 2.4% 1 Group received only 2 doses due to toxicity
We are told to keep the area clean, apply some over-the-counter ointment, and just wait
Maybe they worked for a while, but the effects werent long-lasting as youd hoped, or you encountered some side effects as a result